Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedNo significant changes detected on the Study Details page; the study title, arms, eligibility criteria, primary/secondary outcomes, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedUpdated operating-status notice and version from v3.1.0 to v3.2.0, adding a government funding caveat and links for status details.SummaryDifference1%

- Check42 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not alter core content or other critical data.SummaryDifference0.0%

- Check50 days agoChange DetectedRemoved a 'Back to Top' link; no significant content or functional changes to the page.SummaryDifference0.0%

- Check57 days agoChange DetectedUpdated to v3.0.2 and added a Back to Top link; removed the older v3.0.0 tag—no substantive content changes.SummaryDifference0.1%

- Check65 days agoChange DetectedThe web page has been updated to a new revision, indicating a potential enhancement or bug fix in the content or functionality.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.